C4 Therapeutics, Inc.

NASDAQ:CCCC

1.62 (USD) • At close May 5, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024202320222021202020192018
Operating Activities:
Net Income -105.316-132.493-128.175-83.892-66.335-34.099-15.711
Depreciation & Amortization 1.8181.881.6761.4921.6171.5951.273
Deferred Income Tax 0001.8795.5810.350.066
Stock Based Compensation 29.66227.23530.01621.5123.4321.6420.582
Change In Working Capital 7.648-6.938-16.779-30.09-13.17784.982-5.559
Accounts Receivables 8.697-10.3274.244-1.2320.13981.815-84.944
Inventory 000-2.627-1.582.171-2.222
Accounts Payables -0.1190.273-3.333-1.1790.4674.2310.578
Other Working Capital -0.933.116-17.69-25.052-12.203-3.23581.029
Other Non Cash Items 1.0313.4787.3232.1341.6331.1442.368
Operating Cash Flow -65.157-106.838-105.939-86.965-67.24955.614-16.981
Investing Activities:
Investments In Property Plant And Equipment -0.18-1.708-5.496-1.277-0.65-1.349-2.689
Acquisitions Net 00-63.918188.059189.8550.0630
Purchases Of Investments -284.321-129.898-219.527-537.74-293.855-79-4.99
Sales Maturities Of Investments 233.231289.955283.445349.68110478.66644.6
Other Investing Activites 0063.918-188.059-189.855-0.27139.61
Investing Cash Flow -51.27158.34958.422-189.336-190.505-1.6236.921
Financing Activities:
Debt Repayment 0-12.50011.97300
Common Stock Issued 44.3757.6730.777169.465340.59900.047
Common Stock Repurchased -0.194-0.1100-0.194-0.03-0.063
Dividends Paid 0000000
Other Financing Activities 1.160.4261.1471.935-3.4460.2741.914
Financing Cash Flow 45.33645.4891.147171.4348.9320.2441.961
Other Information:
Effect Of Forex Changes On Cash 0000000
Net Change In Cash -71.09197-46.37-104.90191.17854.23821.901
Cash At End Of Period 58.942130.03333.03379.403184.30493.12638.888